Literature DB >> 8475034

Expression of sequences related to c-myc in Entamoeba.

M Leyva Leyva1, P Gariglio, L M Rangel, J Valdés, P Ayala, E Orozco.   

Abstract

The evolutionarily conserved proto-oncogene c-myc is involved in both proliferation and differentiation processes of higher eukaryotic cells. We report here the identification and characterization of sequences homologous to c-myc in different Entamoeba species using a fragment of the mammalian c-myc gene as a probe. This probe hybridized with fragments of 3.5 and 3.4 kilobases (kb) in E. histolytica HindIII of EcoRI digested DNA. In E. invadens it recognized fragments of 3.1 and 2.8 kb, and in Laredo strain (reported as E. moshkovskii by Clark and Diamond in 1991) the probe hybridized with fragments of 17 kb. The c-myc probe identified transcripts of 3.3 and 1.5 kb in E. histolytica, transcripts of 1.8 and 1.3 kb in Laredo strain, and transcripts of 3.7, 1.8, 1.5 and 1.1 kb in E. invadens. Antibodies against a highly conserved region of the c-myc protein recognized in E. histolytica polypeptides of 35, 40, and 60 kDa. The expression of the 60 kDa polypeptide was temperature-inducible in Laredo strain. In E. invadens a 110 kDa strong band was detected by the antibodies. Surprisingly, E. invadens myc-like sequences and proteins showed greater homology to mammalian c-myc gene and proteins. Expression of proteins antigenically related to c-myc varied according to the cell cycle phase of E. histolytica. These proteins peaked during D, G1, and S phases and declined during G2.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475034     DOI: 10.1007/bf00932262

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  51 in total

1.  Clonal growth of Entamoeba histolytica and other species of Entamoeba in agar.

Authors:  F D Gillin; L S Diamond
Journal:  J Protozool       Date:  1978-11

2.  A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas.

Authors:  S R Hann; M W King; D L Bentley; C W Anderson; R N Eisenman
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality.

Authors:  J A Walsh
Journal:  Rev Infect Dis       Date:  1986 Mar-Apr

5.  Isolation and characterization of RNA of Entamoeba histolytica.

Authors:  R A Albach; V Prachayasittikul; G M Heebner
Journal:  Mol Biochem Parasitol       Date:  1984-07       Impact factor: 1.759

6.  Differential expression of cellular oncogenes during pre- and postnatal development of the mouse.

Authors:  R Müller; D J Slamon; J M Tremblay; M J Cline; I M Verma
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

7.  The Laredo strain and other 'Entamoeba histolytica-like' amoebae are Entamoeba moshkovskii.

Authors:  C G Clark; L S Diamond
Journal:  Mol Biochem Parasitol       Date:  1991-05       Impact factor: 1.759

8.  The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma.

Authors:  J Battey; C Moulding; R Taub; W Murphy; T Stewart; H Potter; G Lenoir; P Leder
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

9.  Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor.

Authors:  R F Doolittle; M W Hunkapiller; L E Hood; S G Devare; K C Robbins; S A Aaronson; H N Antoniades
Journal:  Science       Date:  1983-07-15       Impact factor: 47.728

10.  The protein encoded by the human proto-oncogene c-myc.

Authors:  G Ramsay; G I Evan; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more
  1 in total

1.  Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells.

Authors:  Francis O Enane; Yogen Saunthararajah; Murray Korc
Journal:  Cell Death Dis       Date:  2018-09-06       Impact factor: 8.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.